Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-16 Purchase | 2022-05-17 9:51 pm | TFF Pharmaceuticals Inc. | TFFP | Mattes Glenn R. President and CEO | 16,000 | $4.78 | $76,480 | 43,000 (Indirect Direct) | View |
| 2021-09-16 Purchase | 2021-09-16 1:35 pm | TFF Pharmaceuticals Inc. | TFFP | Mattes Glenn R. President and CEO | 10,000 | $7.1 | $71,000 | 27,000 (Indirect Direct) | View |
| 2021-03-15 Sale | 2021-03-17 8:00 pm | TFF Pharmaceuticals Inc. | TFFP | Mattes Glenn R. President and CEO | 50,000 | $17.04 | $852,000 | 954,227 (Direct) | View |
| 2021-02-16 Sale | 2021-02-18 7:02 pm | TFF Pharmaceuticals Inc. | TFFP | Mattes Glenn R. President and CEO | 40,000 | $16.82 | $672,800 | 1,004,227 (Direct) | View |
| 2020-09-25 Sale | 2021-01-20 8:37 pm | TFF Pharmaceuticals Inc. | TFFP | Mattes Glenn R. President and CEO | 43,000 | $17.47 | $751,400 | 1,051,227 (Indirect Direct) | View |
| 2020-12-23 Sale | 2020-12-29 4:05 pm | TFF Pharmaceuticals Inc. | TFFP | Mattes Glenn R. President and CEO | 30,000 | $15.33 | $459,900 | 1,094,227 (Indirect Direct) | View |
| 2020-11-10 Sale | 2020-11-13 9:00 pm | TFF Pharmaceuticals Inc. | TFFP | Mattes Glenn R. President and CEO | 108,830 | $14.99 | $1,631,906 | 1,124,227 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-03-15 Exercise | 2021-03-17 8:00 pm | N/A N/A | TFF Pharmaceuticals Inc. | TFFP | Mattes Glenn R. President and CEO | 50,000 | $2.5 | 954,227 (Direct) | View |
| 2021-03-15 Exercise | 2021-03-17 8:00 pm | 2019-09-26 2028-09-26 | TFF Pharmaceuticals Inc. | TFFP | Mattes Glenn R. President and CEO | 50,000 | $0 | 954,227 (Direct) | View |
| 2021-02-16 Exercise | 2021-02-18 7:02 pm | N/A N/A | TFF Pharmaceuticals Inc. | TFFP | Mattes Glenn R. President and CEO | 40,000 | $2.5 | 1,004,227 (Direct) | View |
| 2021-02-16 Exercise | 2021-02-18 7:02 pm | 2019-09-26 2028-09-26 | TFF Pharmaceuticals Inc. | TFFP | Mattes Glenn R. President and CEO | 40,000 | $0 | 1,004,227 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-20 8:37 pm | N/A N/A | TFF Pharmaceuticals Inc. | TFFP | Mattes Glenn R. President and CEO | 40,000 | $2.5 | 1,051,227 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-20 8:37 pm | 2019-05-01 2028-05-01 | TFF Pharmaceuticals Inc. | TFFP | Mattes Glenn R. President and CEO | 40,000 | $0 | 1,051,227 (Direct) | View |
| 2020-12-23 Exercise | 2020-12-29 4:05 pm | N/A N/A | TFF Pharmaceuticals Inc. | TFFP | Mattes Glenn R. President and CEO | 30,000 | $2.5 | 1,094,227 (Direct) | View |
| 2020-12-23 Exercise | 2020-12-29 4:05 pm | 2019-05-01 2028-05-01 | TFF Pharmaceuticals Inc. | TFFP | Mattes Glenn R. President and CEO | 30,000 | $0 | 1,094,227 (Direct) | View |
| 2020-11-10 Exercise | 2020-11-13 9:00 pm | N/A N/A | TFF Pharmaceuticals Inc. | TFFP | Mattes Glenn R. President and CEO | 108,830 | $2.5 | 1,124,227 (Direct) | View |
| 2020-11-10 Exercise | 2020-11-13 9:00 pm | 2019-05-01 2028-05-01 | TFF Pharmaceuticals Inc. | TFFP | Mattes Glenn R. President and CEO | 108,830 | $0 | 1,124,227 (Direct) | View |
| 2019-11-29 Option Award | 2020-08-26 6:14 pm | N/A N/A | TFF Pharmaceuticals Inc. | TFFP | Mattes Glenn R. President and CEO | 241,952 | $0 | 2,274,114 (Direct) | View |
| 2019-11-29 Option Award | 2019-12-03 7:38 pm | N/A 2029-10-29 | TFF Pharmaceuticals Inc. | TFFP | Mattes Glenn R. President and CEO | 25,214 | $0 | 971,105 (Direct) | View |